Loading clinical trials...
Loading clinical trials...
Clinical Study of Efficacy and Safety of Chidamide Combined With Cladribine Regimen in Refractory/Relapsed Acute Myeloid Leukemia
Conditions
Interventions
Chidamide
Cladribine
Locations
1
China
Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University
Nanjing, Jiangsu, China
Start Date
June 1, 2021
Primary Completion Date
June 1, 2023
Completion Date
June 1, 2023
Last Updated
April 29, 2022
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT06994676
NCT04628026
Lead Sponsor
Ge Zheng
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions